THU0295 Prophylactic Use of Trimethoprim-Sulfamethoxazole against Pneumocysitis Pneumonia May Reduce the Risk of Bloodstream Infection in Patients with Connective Tissue Diseases Undergoing High-Dose Corticosteroid Therapy

Takuya Kobayashi ,Naoto Yokogawa ,Mayumí Takáhashi ,Yasuaki Tagashira ,Shoko Kawai ,Takashi Kaneko ,Shoji Suzuki

doi:10.1136/annrheumdis-2014-eular.5775

THU0295 Prophylactic Use of Trimethoprim-Sulfamethoxazole against Pneumocysitis Pneumonia May Reduce the Risk of Bloodstream Infection in Patients with Connective Tissue Diseases Undergoing High-Dose Corticosteroid Therapy

Takuya Kobayashi , Naoto Yokogawa + Show 5 more

https://doi.org/10.1136/annrheumdis-2014-eular.5775

Copy DOI

Journal: Annals of the Rheumatic Diseases

Publication Date: Jun 1, 2014

Affiliation: Tokyo Metropolitan Tama Medical Center, Tokyo Metropolitan Children's Medical Center

#Tokyo Metropolitan Tama Medical Center #Connective Tissue Diseases + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

BackgroundProphylaxis with trimethoprim-sulfamethoxazole (TMP/SMP) is highly effective for the prevention of Pneumocysitis pneumonia (PCP) and recommended in patients with connective tissue diseases (CTD) undergoing high-dose corticosteroid therapy.[1] Prophylaxis with TMP-SMZ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.